Meet the group

PharmAccess is a group of non-profit organizations dedicated to improving access to quality healthcare in Africa. PharmAccess mobilizes public and private resources for the benefit of doctors and patients through clinical standards and quality improvements, loans for healthcare providers, health insurance, mHealth innovations and operational research.

This integrated approach is made possible by the following organizations:

Visit website
Visit website
Visit website
Visit website
Country Offices

 Country Offices

 

Ghana
Kenya
Nigeria
Tanzania
Contact
  • Who we are
  • Our approach
  • News & Publications

PharmAccess Foundation
AHTC, Tower 4C
Paasheuvelweg 25
1105 BP Amsterdam
The Netherlands

T: +31 (0)20 2103920
E: info@pharmaccess.org

  • Who we are
  • Our approach
  • News & Publications
Newsroom

Advanced Biological Laboratories and PharmAccess enter licensing agreement to support PASER study

PRESS RELEASE
Luxembourg/Amsterdam, September 13, 2007

  • Sep 18, 2007
Suggested reads
  • Jun 16, 2015
    Mister Sister mobile clinic program wins World Bank PPP Short Story Competition
  • Apr 01, 2014
    Shell and PharmAccess join forces to improve access to affordable quality healthcare in Africa.
  • Mar 12, 2014
    Amerikaanse overheid reikt Impact Award uit aan het Nederlandse Medical Credit Fund

Advanced Biological Laboratories (ABL), S.A., and PharmAccess Foundation today announced the completion of a licensing agreement for the customization of ABL’s proprietary TherapyEdge HIV ViroScore Suite platform to support PharmAccess’ African Studies to Evaluate Resistance (PASER).


Advanced Biological Laboratories (ABL), S.A., and PharmAccess Foundation today announced the completion of a licensing agreement for the customization of ABL’s proprietary TherapyEdge HIV ViroScore Suite platform to support PharmAccess’ African Studies to Evaluate Resistance (PASER), as part of the LAASER-HIV/AIDS Program: Linking African and Asian Societies for an Enhanced Response to HIV/AIDS.

TherapyEdge HIV ViroScore Suite is a HIV-1 sequence database used by clinicians and virologists in over 36 countries to store, organize and analyze HIV resistance information and to link the clinical and virological backgrounds of individuals. In some settings, it allows for the selection of personalized optimal HIV antiretroviral therapy using antiretroviral resistance interpretation systems (six international expert peer reviewed algorithms).

“We are very happy to collaborate with PharmAccess’ dedicated, key-opinion leaders in their efforts to expand access to quality, scientifically sound HIV/AIDS care and treatment in the context of general healthcare in resource limited regions of the world, while continuing to strengthen the knowledge and the science embedded in TherapyEdge HIV ViroScore Suite technology,” said Jean-Claude Schmit, MD, PhD, Chief Scientific Officer of TherapyEdge-ABL.

PharmAccess will utilize TherapyEdge HIV ViroScore Suite primarily for drug resistance surveillance and drug resistance monitoring. This will allow for identification of the major transmitted and acquired HIV resistance mutations in Sub-Saharan Africa, in the context of the various different African HIV subtypes. “Our alliance with ABL will provide state of the art systems which interface with our clinical database, to deliver optimal technology to Africa for HIV resistance interpretation purposes. This eventually provides the opportunity to African policy makers for informed decision making with respect to HIV resistance,” said Tobias Rinke de Wit, PhD, Director Advocacy, Technology and Research for PharmAccess. Inhabited by just over 12% of the world’s population, Africa is estimated to have more than 60% of the AIDS-infected population.

Two virology departments, one based in South Africa and the other in Uganda, will be equipped before year’s end with TherapyEdge HIV ViroScore Suite. They will centralize and process resistance testing for all samples received from several neighboring African countries. Subsequently they will link the resistance information of the PASER study to the clinical information system developed by PharmAccess, using a central server based in Europe. The HIV resistance information is collected in full coordination with the World Health Organization’s (WHO) HIV ResNet system.

>>read more on the PASER study>>

Contact Information
Chalom Sayada (CEO)
Advanced Biological Laboratories (ABL) SA
Phone: +352-2638-8941
http://www.ablsa.com

Tobias Rinke de Wit  (Director Advocacy)
PharmAccess Foundation
Phone: +31-20-566-7626
http://www.pharmaccess.org

About ABL, S.A.
Advanced Biological Laboratories (ABL), S.A., is a biotech company founded in 2000 as a spin-off from the European academic research center, CRP-Santé, Luxembourg and in 2004, merged with TherapyEdge, Inc. ABL’s expertise lies within infectious diseases, with particular focus on resistance patterns and clinical outcome predictors for HIV-1, hepatitis and human papillomavirus (HPV) infections. ABL was selected to supply the technology platform to support the SPREAD HIV resistance study in 16 countries and the EuropeHIVResistance (EU sponsored program) in 32 countries, and is actively participating in both private and public sector research. The ViroScore Suite and TherapyEdge systems are used in over 55 clinics worldwide to support optimal clinical care for individuals with complex diseases. ABL has offices in Luxembourg, South Africa, and the USA, and partners in Asia.

About PharmAccess Foundation
PharmAccess Foundation is a Dutch not-for-profit organization supporting sustainable quality basic health care including HIV/AIDS treatment and care in Sub-Saharan Africa. PharmAccess supports programs and offers services focused on strengthening health systems through building both medical and administrative capacity. Support is provided by:

  • assessing and upgrading clinics, hospitals, laboratories, pharmacies and health insurance companies
  • capacity building for medical, laboratory and administrative staff
  • introducing health insurance
  • mobilizing commercial capital for investment in health, and conducting operational research and monitoring and evaluation.

Specific emphasis is put on the quality of care, without which the willingness to pay for health care and health insurance remains limited. PharmAccess works closely with public and private health care providers, private insurers and companies. It links these private parties with public sector interventions and civil society through ‘public-private partnership’ arrangements.

Share
Quickly go to
  • Home
  • Management & Board
  • Our partners
  • Reporting
  • Vacancies
  • Contact
  • Publications
Follow us
  • Twitter
  • Linkedin
  • Facebook
  • Home
  • Management & Board
  • Our partners
  • Reporting
  • Vacancies
  • Contact
  • Publications
  • Kenya
  • Nigeria
  • Ghana
  • Tanzania
  • Twitter
  • Linkedin
  • PharmAccess@Medium
  • Disclaimer
  • Privacy statement
  • © 2022 PharmAccess Group. All rights reserved.
Our COVID-19 response
To serve you better and more personal we make use of cookies.

Accept
Read more
Change Settings
Cookie Box Settings privacy settings
Cookie Box Settings privacy settings

Privacy settings

Decide which cookies you want to allow. You can change these settings at any time. However, this can result in some functions no longer being available. For information on deleting the cookies, please consult your browser’s help function. Learn more about the cookies we use via our privacy statement.

With the slider, you can enable or disable different types of cookies:

  • Block all
  • Essential
  • Functionality
  • Analytics

This website will:

  • Essential: Remember your cookie permission setting
  • Essential: Allow session cookies
  • Essential: Gather information you input into a contact forms, newsletter and other forms across all pages
  • Essential: Keep track of what you input in a shopping cart
  • Essential: Authenticate that you are logged into your user account
  • Essential: Remember language version you selected

This website won't:

  • Remember your login details
  • Functionality: Remember social media settings
  • Functionality: Remember selected region and country
  • Analytics: Keep track of your visited pages and interaction taken
  • Analytics: Keep track about your location and region based on your IP number
  • Analytics: Keep track of the time spent on each page
  • Analytics: Increase the data quality of the statistics functions
  • Advertising: Tailor information and advertising to your interests based on e.g. the content you have visited before. (Currently we do not use targeting or targeting cookies.
  • Advertising: Gather personally identifiable information such as name and location

This website will:

  • Essential: Remember your cookie permission setting
  • Essential: Allow session cookies
  • Essential: Gather information you input into a contact forms, newsletter and other forms across all pages
  • Essential: Keep track of what you input in a shopping cart
  • Essential: Authenticate that you are logged into your user account
  • Essential: Remember language version you selected
  • Functionality: Remember social media settings
  • Functionality: Remember selected region and country

This website won't:

  • Remember your login details
  • Analytics: Keep track of your visited pages and interaction taken
  • Analytics: Keep track about your location and region based on your IP number
  • Analytics: Keep track of the time spent on each page
  • Analytics: Increase the data quality of the statistics functions
  • Advertising: Tailor information and advertising to your interests based on e.g. the content you have visited before. (Currently we do not use targeting or targeting cookies.
  • Advertising: Gather personally identifiable information such as name and location

This website will:

  • Essential: Remember your cookie permission setting
  • Essential: Allow session cookies
  • Essential: Gather information you input into a contact forms, newsletter and other forms across all pages
  • Essential: Keep track of what you input in a shopping cart
  • Essential: Authenticate that you are logged into your user account
  • Essential: Remember language version you selected
  • Functionality: Remember social media settingsl Functionality: Remember selected region and country
  • Analytics: Keep track of your visited pages and interaction taken
  • Analytics: Keep track about your location and region based on your IP number
  • Analytics: Keep track of the time spent on each page
  • Analytics: Increase the data quality of the statistics functions

This website won't:

  • Remember your login details
  • Advertising: Use information for tailored advertising with third parties
  • Advertising: Allow you to connect to social sites
  • Advertising: Identify device you are using
  • Advertising: Gather personally identifiable information such as name and location

This website will:

  • Essential: Remember your cookie permission setting
  • Essential: Allow session cookies
  • Essential: Gather information you input into a contact forms, newsletter and other forms across all pages
  • Essential: Keep track of what you input in a shopping cart
  • Essential: Authenticate that you are logged into your user account
  • Essential: Remember language version you selected
  • Functionality: Remember social media settingsl Functionality: Remember selected region and country
  • Analytics: Keep track of your visited pages and interaction taken
  • Analytics: Keep track about your location and region based on your IP number
  • Analytics: Keep track of the time spent on each page
  • Analytics: Increase the data quality of the statistics functions
  • Advertising: Use information for tailored advertising with third parties
  • Advertising: Allow you to connect to social sitesl Advertising: Identify device you are using
  • Advertising: Gather personally identifiable information such as name and location

This website won't:

  • Remember your login details
Save & Close